Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6066-6072
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6066
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6066
Table 1 Comparison of the clinical outcomes between the two study groups, n (%)
| Group | Visible effect | Effective | Invalid | Total validity |
| Control group (n = 51) | 15 (29.41) | 19 (37.25) | 17 (33.33) | 34 (66.67) |
| Observation group (n = 51) | 25 (49.02) | 20 (39.22) | 6 (11.76) | 45 (88.24) |
| χ2 value | 6.793 | |||
| P value | 0.009 |
- Citation: Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6066